Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > DRIP DRIP DRIP
View:
Post by Kd5513 on Aug 03, 2023 11:03am

DRIP DRIP DRIP

Slow burn on the stock price, PR around first patient in trial would at least stop the bleeding for a few days, but Paul knows better I guess.
Comment by JasontheGreat on Aug 03, 2023 11:22am
Paul knows nothing but how to destroy a company and collecting a paycheck
Comment by PWIB123 on Aug 03, 2023 11:42am
How long does it take to restart a trial?  I'm curious what all goes into it, but considering they were already running, it doesn't seem like it would take a huge amount of effort to restart.  Maybe there's more to it, but we are now 61 days and counting from the FDA agreement to restart.  Makes you wonder if they are going to have a lengthy delay or if they haven't ...more  
Comment by juniper88 on Aug 03, 2023 1:35pm
It shouldn't take long at all to restart the trial.  I remember Thera once stating that they would restart the trial by the end of June.  Unfortunately, something is amiss here and we, as usual, are being kept in the dark.  Is there a a technical reason?  Does the new agreement with Marathon have something to do with this?   To those who thought that we might see ...more  
Comment by palinc2000 on Aug 03, 2023 3:34pm
As you know the new enrolment criteria  require a lot of screening and tests and research for each patient that will be selected for the trial! What will be the ratio between  the number of patients selected vs  the number of patients referred  Very low I expect thus very time consuming
Comment by juniper88 on Aug 03, 2023 4:03pm
This is what the press release stated about the new protocol : narrowing of the patient population to focus on those with high-grade serous ovarian cancer, including high-grade peritoneal or fallopian tube cancer, or high-grade endometrioid cancer - a population in which preliminary efficacy has been observed thus far. Patient selection has also been refined to focus on those who are less heavily ...more  
Comment by palinc2000 on Aug 03, 2023 4:32pm
I did not think that patients selection was only based on paperwork...Thx for your clarification I just reread part of the transcripts of the last CC and they did say first patient in July and Marsolais said patient selection would be fast.....
Comment by Trogarzon on Aug 03, 2023 4:39pm
In the Q2 call thet said that Th1902 trial will be resarted in the coming weeks.  After a mount I think the wording shoud be in the coming months....  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities